Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
23-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #67231
advertisement
Tao Y
31
Showing records 1 to 25 |
Display all abstracts from
Tao Y
106926
A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022
Tao Y
Frontiers in cell and developmental biology
2023; 11: 1081898
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Li Q
Molecular Biology Reports
2023; 50: 1321-1331
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Li J
iScience
2023; 26: 105755
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Jiang J
Ophthalmic Research
2022; 0:
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Feng P
Molecular Biology Reports
2023; 50: 1321-1331
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Wang D
iScience
2023; 26: 105755
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Xu J
Ophthalmic Research
2022; 0:
106926
A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022
Zhang Q
Frontiers in cell and developmental biology
2023; 11: 1081898
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Pottenburgh J
iScience
2023; 26: 105755
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Lin S
Molecular Biology Reports
2023; 50: 1321-1331
106926
A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022
Meng M
Frontiers in cell and developmental biology
2023; 11: 1081898
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Tao Y
Ophthalmic Research
2022; 0:
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Bower AJ
iScience
2023; 26: 105755
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Hu C
Ophthalmic Research
2022; 0:
106926
A bibliometric analysis of the application of stem cells in glaucoma research from 1999 to 2022
Huang J
Frontiers in cell and developmental biology
2023; 11: 1081898
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Xu Z; Zhao J
Molecular Biology Reports
2023; 50: 1321-1331
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Zhang C
Ophthalmic Research
2022; 0:
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Asanad S
iScience
2023; 26: 105755
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Chen Z
Molecular Biology Reports
2023; 50: 1321-1331
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Lai EW
iScience
2023; 26: 105755
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Sun X
Ophthalmic Research
2022; 0:
106552
Crocetin confers neuroprotection and is anti-inflammatory in rats with induced glaucoma
Luo Z
Molecular Biology Reports
2023; 50: 1321-1331
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Ye C
Ophthalmic Research
2022; 0:
106795
Visualization of erythrocyte stasis in the living human eye in health and disease
Simon C
iScience
2023; 26: 105755
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Zhang S
Ophthalmic Research
2022; 0:
«
1
2
»
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept